What is AORT's health score?

ARTIVION, INC. (AORT) has a TradeApes health score of 62 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is AORT's estimated fair value?

Based on our 5-year discounted cash flow model, ARTIVION, INC.'s estimated fair value is $2.79 per share, representing a -87.4% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is AORT undervalued or overvalued?

Our model currently rates AORT as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for AORT... Refresh in a moment for the full analysis.

ARTIVION, INC. (AORT)

Healthcare Overvalued low healthy

$22.19

Updated: 2026-06-01

TradeApes Score

Financial Strength

70 Healthy

Operating Trend

76 Strong

Relative Value

50 Mixed

Capital Allocation

40 Weak

Risk

70 Healthy

Est. Fair Value $2.79

DCF Upside -87.4%

Sector Rank #236 of 6890

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.